Evidence map›Paper›PMID 35993001›Full record

ArticleSovremennye tekhnologii v meditsine2022

Selection of the Optimal Method for Creating Various Forms of Biocompatible Xenodermal Materials.

К I Melkonyan, Y А Kozmai, А А Verevkin, Т V Rusinova, А S Asyakina, М L Zolotavina

Open access · diamondAbstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

К I MelkonyanAssociate Professor, Head of the Central Research Laboratory; Kuban State Medical University, 4 Mitrofana Sedina St., Krasnodar, 350063, Russia.
Y А KozmaiJunior Researcher, Central Research Laboratory; Kuban State Medical University, 4 Mitrofana Sedina St., Krasnodar, 350063, Russia.
А А VerevkinResearcher, Central Research Laboratory; Kuban State Medical University, 4 Mitrofana Sedina St., Krasnodar, 350063, Russia.
Т V RusinovaResearcher, Central Research Laboratory; Kuban State Medical University, 4 Mitrofana Sedina St., Krasnodar, 350063, Russia.
А S AsyakinaAssistant Researcher; Kuban State Medical University, 4 Mitrofana Sedina St., Krasnodar, 350063, Russia; Graduate Student, Department of Genetics, Microbiology, and Biochemestry; Kuban State University, 149 Stavropolskaya St., Krasnodar, 350040, Russia.
М L ZolotavinaAssociate Professor, Department of Genetics, Microbiology, and Biochemestry; Kuban State University, 149 Stavropolskaya St., Krasnodar, 350040, Russia.
Central Research Institute · INCentral Research Laboratories (United Kingdom) · GBBioChem Technology (United States) · USKuban State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: To create xenodermal biomaterials, the native skin of a 4-month-old Landrace pig was used. The porcine dermis was processed with saline (protocol No.1), peroxide-alkaline (protocol No.2), and alkaline (protocol No.3) solutions. The obtained samples were stained with hematoxylin-eosin and a DAPI fluorescent dye. Quantitative DNA analysis and assessment of cytotoxicity by the LIVE/DEAD assay were also performed. Samples were implanted/injected subcutaneously to 6-month-old male Wistar rats (n=30) weighing 260±20 g and explanted on day 14 of the experiment. Histological sections were stained with hematoxylin-eosin. Computer morphometry was performed using GraphPad Prism v. 6.04. Results: Samples of surgical materials obtained according to the three protocols had different physical characteristics: dermis treated according to protocol No.1 was dense and white in color after processing; samples processed by protocol No.2 were transparent and dense, and samples treated according to protocol No.3 had transparent gel-like structures. Histological analysis has shown oxyphilicity and extracellular matrix structure loss in all samples, and DAPI staining has revealed the destruction of cell nuclei. Nevertheless, DNA amount in the samples processed according to protocol No.1 did not meet the established quality criterion for decellularization (50 ng/mg dry weight). Further cytotoxicity assessment Conclusion: To obtain surgical materials in the form of bioplastic coatings, it is recommended to use alkaline-peroxide treatment of the dermis, while hydrogel coatings are produced by alkaline hydrolysis.

Indexed as

Biocompatible MaterialsDNAAnimalsEosine Yellowish-(YS)HematoxylinMalePeroxidesRatsRats, WistarSwineBiocompatible MaterialsDNAEosine Yellowish-(YS)HematoxylinPeroxidesalkaline hydrolysisdecellularizationdermissurgical biomaterialsxenodermal biomaterials

Identifiers

PMID35993001
PMCPMC9376758
OpenAlexW4214696035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.